Target intelligence / Profile preview

Avian influenza A hemagglutinin subtype 5 protein (Hemagglutinin H5)

Target
Hemagglutinin H5
Molecular classification
Glycoprotein, Class I fusion protein, Viral envelope protein, Receptor-binding protein
01

Overview

The Avian influenza A hemagglutinin subtype 5 protein (Hemagglutinin H5, or H5 HA) is a trimeric glycoprotein located on the surface of avian influenza A viruses, most notably associated with the highly pathogenic H5N1 strains. Each monomer of the trimer contains a globular head (HA1), responsible for binding to sialic acid receptors on the host cell surface, and a stalk region (HA2), which facilitates the fusion of viral and host membranes—an essential step in infection. The H5 subtype is distinguished by a polybasic cleavage site, processed by ubiquitous host proteases, and is linked to high systemic pathogenicity. The HA protein is a key target for neutralizing antibodies and vaccine development, yet its high sequence variability—particularly in the head domain—enables viral escape from host immunity. H5 HA-mediated host cell entry underpins the spread and severity of avian influenza outbreaks, with zoonotic infection and potential pandemic risk stemming from mutations that enhance human receptor binding.

Other names
Influenza A H5 hemagglutininH5 HAHA subtype 5Hemagglutinin (H5)Avian influenza hemagglutinin H5
02

Mechanism of action

Antibody binding blocks receptor engagement or inhibits structural rearrangement needed for membrane fusion. Inhibitors may target the fusion peptide or interfere with proteolytic activation by host proteases, preventing the HA conformational changes required for viral entry.

03

Biological functions

Receptor binding (mediates viral attachment to host cell sialic acid receptors)Membrane fusion (enables fusion of viral and host membranes during cell entry)Immune evasion (frequent mutation and variation in the head domain helps escape antibody recognition)
04

Disease associations

Infection (plays a critical role in transmission and pathogenicity of avian influenza, including zoonotic transmission to humans)High-pathogenicity (especially in H5N1, associated with severe disease and fatalities in birds and humans)Emerging pandemic threat (H5N1 subtype is monitored for pandemic potential)
05

Safety considerations

High variability in HA, especially in the receptor-binding domain (complicates development of universal antibodies and vaccines)Polybasic cleavage site in H5 is associated with increased pathogenicity and systemic spread, raising biosafety concernsAntibody escape due to rapid mutation (antigenic drift)Occasional zoonotic transmission and adaptation to humans, with pandemic potential
06

Interacting drugs

Antibodies (neutralizing monoclonal antibodies targeting the stalk or head of HA protein; research includes F10, C05, broad-spectrum nAbs)

2 more in the full profile.

07

Biomarkers

Cleavage site sequence (distinguishes high-pathogenicity from low-pathogenicity strains; polybasic sites favor systemic infection)Host antibody titer against H5 HA (used for efficacy monitoring in vaccines)HA subtype sequencing (used in diagnostics to identify circulating strains and guide vaccine formulation)

Beyond the preview

Go deeper on Avian influenza A hemagglutinin subtype 5 protein (Hemagglutinin H5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avian influenza A hemagglutinin subtype 5 protein (Hemagglutinin H5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call